INTRODUCTION
Cells maintain protein homeostasis (proteostasis) under a variety of metabolic states and growth conditions. Molecular chaperones and the protein degradation machinery cooperate within a complex protein quality control network to prevent the accumulation of potentially toxic misfolded proteins in the cytosol and within subcellular compartments (Douglas and Dillin, 2010; Hartl et al., 2011; Powers et al., 2009) . Chaperones assist protein folding, prevent aggregation, mediate the refolding of misfolded proteins, and transfer terminally misfolded proteins to proteolytic degradation by the ubiquitin-proteasome system (UPS) or autophagy (Rubinsztein, 2006) . These mechanisms must be tightly regulated to maintain proper proteome balance. Failure of proteostasis control has been associated with the age-dependent manifestation of a number of neurodegenerative aggregatedeposition diseases, including Parkinson's and Huntington's disease. Multiple lines of evidence suggest that ongoing protein aggregation further compromises the proteostasis system, aggravating cellular pathology (Douglas and Dillin, 2010; Gidalevitz et al., 2010) .
Pathological protein aggregation concurrent with declining proteostasis capacity has been documented extensively in cellular and organismal models of polyglutamine (polyQ) expansion diseases, such as Huntington's disease and various forms of ataxia. For example, expression of pathological polyQ proteins in nematode and cellular models causes loss of function of chaperone-dependent, metastable proteins (Gidalevitz et al., 2006; Gupta et al., 2011) . Moreover, polyQ expansion proteins can impair normal UPS function by mechanisms that are not yet well understood (Bence et al., 2001; Bennett et al., 2005; Duennwald and Lindquist, 2008; Hipp et al., 2012a; Rousseau et al., 2009; Venkatraman et al., 2004; Verhoef et al., 2002) .
In the present study we analyzed how expanded polyQ proteins interfere with the clearance of misfolded cytosolic proteins via the UPS. Detailed investigations were performed in a yeast model and key observations were then confirmed in human HEK293 cells. UPS-mediated quality control was measured with cytosolic carboxypeptidase Y* fused to green fluorescent protein (GFP) (CG*) as a misfolded reporter protein (Heck et al., 2010; Park et al., 2007; Prasad et al., 2010) . Expression of polyQ-expanded huntingtin exon 1 with 96Q or a C-terminal fragment of ataxin 3 with 71Q markedly inhibited the degradation of CG*. Quantitative interactome analysis identified the essential but low-abundant Hsp40 chaperone Sis1p as a strong interactor of soluble polyQ aggregates and of insoluble polyQ inclusions. Surprisingly, we discovered that Sis1p, and similarly its close human homolog DnaJB1, has a specific role in transporting CG* and other misfolded proteins into the nucleus for proteasomal degradation. By functionally depleting the rate-limiting Hsp40 chaperone, polyQ aggregation disables this quality control pathway, thus augmenting protein misfolding and aggregate deposition in the cytosol.
RESULTS

PolyQ Aggregation Inhibits Degradation of Misfolded Cytosolic Proteins
We used yeast as a model organism to analyze the effect of polyQ-expanded proteins on the clearance of misfolded cytosolic proteins. CG*, a mutant version of the secretory protein carboxypeptidase Y lacking the signal sequence (DssCPY*) and fused to GFP ( Figure 1A ), served as the reporter protein. CG* is unable to fold in the reducing environment of the cytosol and undergoes rapid UPS-mediated degradation in a manner dependent on cytosolic Hsp70 (Ssa1p) and Hsp40 (Ydj1p) (Park et al., 2007) . Degradation occurs, at least in part, by nuclear proteasome complexes (Heck et al., 2010; Prasad et al., 2010) . CG* was expressed under the PRC1 promoter, whereas normal and pathological versions of huntingtin exon 1 with 20 glutamines (20Q) and 96 glutamines (96Q), respectively, were expressed under a galactose-inducible (GAL1) promoter (Krobitsch and Lindquist, 2000; Meriin et al., 2002) (Figure 1A ). These experiments were performed under otherwise nonstress growth conditions at 30 C. After 9 hr of induction, SDS-insoluble 96Q aggregates were detectable by SDS-PAGE or filter-trap assay of cell extracts (Figures 1B and S1A available online). Somewhat larger amounts of SDS-insoluble 96Q accumulated when 96Q and CG* were coexpressed ( Figure S1A ). The turnover of CG* was assessed by inhibition of protein synthesis with cycloheximide (CHX). Rapid degradation of CG* was observed after 6 hr of 96Q expression ( Figure 1C ). However, after 15 hr of 96Q expression, degradation of CG* was strongly inhibited, whereas rapid turnover was preserved with expression of 20Q ( Figure 1C ). CG* degradation was also impaired upon expression of an unrelated polyQ protein, AT3c71Q, an aggregating C-terminal fragment of ataxin 3 with 71Q ( Figure S1B ) (Haacke et al., 2006) . This indicates that inhibition of protein clearance does not depend on the specific sequence context of the polyQ segment.
To examine whether the inhibition of degradation was due to coaggregation of CG* with 96Q, we expressed 96Q as a C-terminal fusion with mCherry fluorescent protein (96QmCh). CG* was also under control of the GAL1 promoter in these experiments, which results in higher expression levels than the PRC1 promoter. 96QmCh preserved the ability to inhibit CG* degradation and cytoplasmic CG* inclusions were generally observed ( Figure 1D ). However, the CG* inclusions did not overlap with the inclusions formed by 96QmCh ( Figure 1D ) and no SDSresistant CG* protein was detected ( Figure S1A ). Similar observations were made upon expression of AT3c71Q ( Figure S1C ).
Neither the expression of 96Q nor of CG* alone resulted in an overt growth defect in yeast cells (Behrends et al., 2006; Krobitsch and Lindquist, 2000) . However, when combined with 96Q, low levels of CG* expressed from the PRC1 promoter Figure S1 .
were sufficient to cause a substantial growth retardation (Figure 1E) , suggesting a breakdown of proteostasis control.
96Q Inhibits CG* Degradation without Blocking Ubiquitylation or Proteasome Function
How do polyQ expansion proteins inhibit the degradation of misfolded cytosolic proteins via the UPS? The interference with protein clearance might occur upstream of the proteasome, at the level of accessory chaperone factors and/or ubiquitylation ( Figure 2A ). Alternatively, aggregating polyQ might block the proteolytic chamber of the 20S proteasome and/or inhibit the function of the 19S regulatory particle (Figure 2A ). These possibilities are not mutually exclusive. First, we tested whether the proteasome is inhibited by 96Q. To this end we used GFP tagged at the C terminus with the 37 amino acid degron of ornithine decarboxylase (cODC), which targets the protein to the 26S proteasome in a ubiquitinindependent manner (Zhang et al., 2003) . Coexpression of 96QmCh did not interfere with the rapid turnover of GFPcODC, even though CG* degradation was inhibited ( Figure 2B ). Moreover, when cODC was fused to the C terminus of 96Q (96QcODC), the resulting fusion protein was effectively degraded ( Figure S2A ), and the block of CG* degradation was partially relieved ( Figure 2C ). In contrast, 96Q carrying the mutated cODC(C441A) degron (96QcODC*) (Zhang et al., 2003) was stabilized ( Figure S2A ) and interfered with CG* degradation ( Figure 2C ). These results exclude direct proteasome inhibition by 96Q as the cause of CG* stabilization in our experimental system. Next, we tested whether CG* was efficiently ubiquitylated in the presence of 96Q. These experiments were performed in cells expressing His 6 -ubiquitin (His 6 -Ub). Inhibition of CG* degradation by 96Q was preserved ( Figure S2B ) and ubiquitylated proteins were isolated from cell extracts by talon magnetic beads under denaturing conditions (see Figure S2C for input fractions). When CG* was expressed either alone or together with 20QmCh or 96QmCh, ubiquitylated CG* was detected in pull-downs by immunoblotting with anti-CPY antibody (Figure 2D , lanes 5-7). Coexpression with 96QmCh did not reduce the amount of ubiquitylated CG* ( Figure 2D , lane 7). To test whether ubiquitylation of CG* was limiting for degradation, we overexpressed the E3 ubiquitin ligase Ubr1p, which is involved in the ''N end rule'' degradation pathway and is also required for efficient CG* degradation (Eisele and Wolf, 2008; Heck et al., 2010; Varshavsky, 2012) . Ubr1p overexpression did not rescue CG* degradation in the presence of 96QmCh, but stimulated degradation in 20QmCh expressing cells ( Figure S2D ). In summary, 96Q does not interfere directly with the function of the proteasome or inhibit CG* ubiquitylation.
Identification of 96Q Interactors
The results described above suggested that 96Q inhibits CG* degradation by sequestering one or more factors required upstream of the proteasome, in addition to ubiquitylation. Figure S2 .
To identify proteins that preferentially interact with 96Q relative to 20Q, we performed a quantitative interactome analysis using SILAC (stable isotope labeling with amino acids in cell culture) (Ong and Mann, 2006) . Cells expressing 96QmCh and CG* were labeled for 20 hr with heavy lysine isotope, while 20QmCh and CG* expressing cells grown in light medium served as control. 96QmCh and 20QmCh were isolated with anti-myc antibodies ( Figure 1A ) from cell extracts that had been clarified by centrifugation to remove polyQ inclusions. The isolated fractions were mixed 1:1, separated by SDS-PAGE, followed by in-gel digestion and LC-MS/MS analysis. Approximately 100 proteins were found to be enriched >2-fold (up to $100-fold) in pull-downs of 96QmCh over 20QmCh in at least two of three independent experiments (Table S1 ). Among the highly enriched interactors are several Q-rich proteins (Pub1, Sgt2, and Def1) and known yeast prion proteins (Rnq1, Sup35, Cyc8, and Pin3) (Table S1 ). Q-rich proteins tend to coaggregate with pathological polyQ proteins (Schaffar et al., 2004) . The association of 96Q with the Q/N-rich prion proteins likely reflects the requirement of the prion status for the seeding of polyQ aggregation in yeast (Meriin et al., 2002) . Two groups of 96Q interactors were of particular interest in the functional context of protein degradation, molecular chaperones (and cochaperones) and components of the UPS ( Figure 3A ). The latter included the highly enriched protein Dsk2 and several moderately enriched subunits of the 19S proteasome complex. Dsk2 contains ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains and is involved in the delivery of polyubiquitylated proteins to the proteasome. However, Dsk2 is dispensable for CG* degradation (Medicherla et al., 2004) , and we found that Dsk2 deletion even accelerated CG* turnover (data not shown), ruling out functional depletion of Dsk2 by 96Q as the cause of CG* stabilization.
The chaperone proteins associated with 96Q included several factors of the Hsp70 system, with the type II Hsp40, Sis1p, being $30-fold enriched on 96Q over 20Q ( Figure 3A ). Sis1p, a homodimer of 38 kDa subunits, is an essential but low-abundant cochaperone of the Ssa class of Hsp70s (Yan and Craig, 1999 ). It appears to be functionally unique compared to other Hsp40s (Kampinga and Craig, 2010; Yan and Craig, 1999) and is critical for yeast prion propagation (Sondheimer et al., 2001; Summers et al., 2009) . The association of Sis1p with insoluble 96Q inclusions was analyzed by fluorescence complementation. The SIS1 gene was replaced by a construct encoding Sis1p fused to the N-terminal half of Venus fluorescent protein (Sis1-VN). 20Q and 96Q were expressed as fusions with the C-terminal half of Venus (20Q-VC, 96Q-VC). A strong association of Sis1-VN with inclusions of 96Q-VC was observed by Venus fluorescence ( Figure 3B ). Indeed, upon cell fractionation, $50% of endogenous Sis1p was recovered in the pellet fraction of lysates from 96Q expressing cells, compared to only $8% in 20Q expressing cells ( Figure S3A ). Moreover, $50% of soluble Sis1p was specifically associated with soluble 96Q species ( Figure S3B ), which included oligomeric complexes fractionating at 400-700 kDa (data not shown). Similarly, a large fraction of Sis1p was insoluble upon expression of AT3c71Q and soluble species of AT3c71Q were also associated with Sis1p ( Figures S3C  and S3D ).
Sis1p Is Rate Limiting for CG* Degradation Molecular chaperones recognize and stabilize terminally misfolded proteins for degradation . We therefore tested whether Sis1p sequestration by 96Q caused the inhibition of CG* degradation. In support of this possibility, overexpression of Sis1p fully restored the degradation of CG* ( Figure 3C ) and markedly suppressed the formation of 96QmCh inclusions (Figure 3D) . Notably, Sis1p overexpression does not cure yeast cells of the [RNQ1+] prion (Hines et al., 2011 ) and thus does not suppress polyQ aggregation by reversing the prion state. Surprisingly, overexpression of the abundant type I Hsp40, Ydj1p; the constitutive Hsp70, Ssa1p; or the small heat shock protein, Hsp42p, failed to restore CG* degradation (Figures S3E and S3F and data not shown). This was the case even though the solubility of both CG* and 96Q was improved (Figures 3E and S3G) and CG* was diffusely distributed in the cytosol upon overexpression of Ydj1p ( Figure 3E ). Furthermore, overexpression of Ydj1p or Ssa1p tended to retard CG* degradation even in control cells expressing 20Q ( Figures S3E and S3F ). Sis1p overexpression fully rescued the growth defect of cells coexpressing 96Q and CG* ( Figure S3H ). These findings pointed to a specialized role of Sis1p in maintaining proteostasis by mediating the degradation of misfolded proteins.
To determine whether Sis1p is normally involved in the clearance of misfolded proteins, we depleted Sis1p in yeast cells (not expressing polyQ protein), in which the SIS1 promoter was replaced by a tetracycline-regulated promoter (Tet-Off). Replacing the promoter reduced Sis1p levels by about 25% compared to wild-type ( Figure 4A, top left) . Notably, this moderate reduction was already sufficient to strongly retard the degradation of CG* ( Figure 4A , bottom left), to an extent comparable to the inhibition observed upon 96Q expression ( Figures 1C and 3C) . Addition of doxycycline (DOX), resulting in $85% Sis1p depletion within 20 hr ( Figure 4A , top right), had only a mild additional effect on CG* degradation ( Figure 4A , bottom right). The inhibition of CG* degradation upon Sis1p depletion was not due to loss of CG* ubiquitylation, as determined by immunoprecipitation of CG* followed by antiubiquitin immunoblotting ( Figure S4A ; see also Figures 2D and S2C ). In conclusion, the data indicate that Sis1p is rate limiting for CG* turnover, likely at a postubiquitylation step. Sequestration of Sis1p by polyQ aggregates is therefore sufficient to explain the stabilization of CG* in 96Q expressing cells.
Sis1p
Cooperates with Hsp70 in the Degradation of Misfolded Proteins Does Sis1p cooperate with cytosolic Hsp70s in CG* degradation? Functional cooperation between Hsp40s and Hsp70 depends on the His-Pro-Asp (HPD)-loop segment in the Hsp40 J domain (Kampinga and Craig, 2010) . We mutated the HPD-loop residues of Sis1p to alanine (Sis1AAA) or deleted residues 1-76 comprising the entire J domain (Sis1DJ). The mutant proteins were expressed in cells depleted of endogenous Sis1p to test whether they could support CG* degradation. In contrast to Sis1p, Sis1AAA did not mediate rapid degradation of CG*, which formed inclusions in the cytoplasm ( Figure 4B and data not shown). These results indicate that Sis1p functionally cooperates with Hsp70 in CG* degradation. To confirm the physical interaction, we immunoprecipitated Sis1p, Sis1DJ, or Sis1AAA with antibodies against their N-terminal HA-tag, followed by immunoblot analysis ( Figure 4C ). All Sis1p proteins tested formed ternary complexes with Ssa1p and CG*, with increased amounts of CG* being recovered with Sis1DJ and Sis1AAA. The amount of Ssa1p in the complexes was reduced for Sis1DJ. These findings are consistent with Sis1p binding to CG* and recruiting the Hsp70 via the Sis1p J domain, perhaps allowing a more stable interaction of Hsp70 with ubiquitylated substrate than in the presence of Ydj1p.
To test whether Sis1p is generally required for the degradation of cytosolic proteins, we analyzed the catabolite-regulated degradation of fructose-1,6-bisphosphatase (FBPase), a key enzyme in gluconeogenesis. FBPase is expressed when cells are grown in nonfermentable carbon sources but is rapidly degraded via the UPS upon addition of glucose (Juretschke et al., 2010) . FBPase was degraded with equivalent kinetics in wild-type and Sis1p-depleted cells ( Figure 4D ). Likewise, Sis1p was not required for the degradation of the short-lived protein Ub G76V -GFP ( Figure S4B ). In conclusion, Sis1p appears to be specifically required for the degradation of misfolded cytosolic proteins and cooperates in this function with Hsp70.
Sis1p is Required for Delivery of CG* to the Nucleus for Degradation One strategy of cytosolic quality control in yeast is to transfer misfolded proteins for degradation into the nucleus, which contains 70%-80% of cellular proteasome complexes (Russell et al., 1999) . This pathway also contributes to the clearance of CG* (Heck et al., 2010; Prasad et al., 2010) , but how misfolded proteins are recognized in the cytosol and imported into the nucleus has remained unclear. Accordingly, we tested the possible involvement of Sis1p in this process. Interestingly, CG* accumulated in large cytoplasmic inclusions when Sis1p was strongly ($85%) or moderately ($25%) depleted ( Figures 5A and S5A ), consistent with a role of Sis1p in delivering CG* to the nucleus. Indeed, we confirmed that degradation of CG* occurs predominantly, if not exclusively, in the nucleus: targeting CG* to the nucleus by a nuclear localization signal (NLS-CG*) substantially accelerated its degradation ( Figure 5B ), whereas attachment of a nuclear export signal (NES-CG*) dramatically stabilized the protein ( Figure 5B ). Next, we analyzed the subcellular location of CG* and Sis1p upon inhibition of proteasome function with MG132. These experiments were performed in Dpdr5 cells lacking the ABC transporter Pdr5 and allowing the intracellular accumulation of the inhibitor. Fluorescence imaging of MG132-treated cells demonstrated the presence of CG* in juxtanuclear, cytoplasmic inclusions ( Figure 5C ). In addition, a fraction of CG* was diffusely distributed in the nucleus. Interestingly, Sis1p almost exclusively localized to the nucleus upon proteasome inhibition ( Figure 5C ), suggesting that its depletion from the cytoplasm triggered the deposition of CG* in inclusions. Similar observations were made in cells lacking the nuclear E3 ligase San1p (Gardner et al., 2005) , which acts in parallel with Ubr1 in CG* degradation (Heck et al., 2010) . Again CG* accumulated in juxtanuclear inclusions and in the nucleus ( Figure 5D ). Relocation of Sis1p to the nucleus was clearly detectable but less pronounced than upon MG132 treatment, consistent with only partial inhibition of CG* degradation in Dsan1 cells (Heck et al., 2010) . Notably, some accumulation of Sis1p in the nucleus was also observed upon proteasome inhibition in cells not expressing CG* (Figure S5B ), presumably reflecting a general role of Sis1p in the nuclear degradation of misfolded cytosolic proteins.
Having established that Sis1p has a role in delivering the terminally misfolded CG* into the nucleus, we asked whether inhibition of Sis1p shuttling between the cytoplasm and the nucleus interferes with CG* degradation. We constructed versions of Sis1p with a N-terminal nuclear export signal (NES-Sis1p) or nuclear import signal (NLS-Sis1p) and expressed them in cells depleted of endogenous Sis1p. NLS-Sis1p was efficiently targeted to the nucleus, whereas NES-Sis1p was diffusely distributed in the cytoplasm ( Figure 5E ). Neither protein was able to restore CG* degradation and cytoplasmic CG* inclusions formed in both cases. Notably, NES-Sis1p also afforded substantial CG* stabilization in wild-type cells containing normal levels of Sis1p ( Figure S5C ), perhaps through formation of mixed dimers with wild-type Sis1p. This dominant inhibitory effect suggests that NES-Sis1p engages CG* but mediates its export from the nucleus before transfer to the nuclear UPS machinery is achieved.
Sis1p has no nuclear targeting sequence but was reported to accumulate in the nucleus upon heat stress in a manner dependent on the essential importin-a, Srp1 (Malinovska et al., 2012) . Indeed, CG* was partially stabilized in cells hypomorphic for SRP1 compared to the corresponding wild-type strain (Figure S5D) (Breslow et al., 2008) , consistent with a direct or indirect role of Srp1p in the pathway of nuclear CG* degradation. Figure S4 .
In summary, Sis1p is an essential element of a quality control pathway that mediates the removal of cytosolic misfolded proteins to the nucleus for proteasomal degradation. When the production of misfolded substrates exceeds the transport capacity of Sis1p, these proteins are deposited in cytosolic inclusions.
Role of Sis1p Homolog in Protein Degradation in Mammalian Cells
To test whether the key observations from the yeast model can be reproduced in mammalian cells, we generated HEK293 cells stably expressing DssCPY*-mCherry (CmCh*). CmCh* was mainly localized in the cytosol ( Figure S6A ). Addition of CHX resulted in its rapid degradation with a half-time of $2 hr (Figure S6B) . Proteasome inhibition caused the accumulation of CmCh* concomitant with the formation of nuclear and juxtanuclear inclusions ( Figures S6A and S6C ), indicating that in mammalian cells, as in yeast, a misfolded protein that is normally localized in the cytosol is degraded in the nucleus. Downregulation of DnaJB1, one of several human homologs of Sis1p, by siRNA slowed the turnover of CmCh* (t 1/2 $4.5 hr) ( Figure S6B ), suggesting that the chaperone is involved in nuclear protein degradation. Next, we analyzed the effect of polyQ proteins on CmCh* clearance by transiently transfecting CmCh* cells with 97Q or 25Q fused to GFP (97QG and 25QG, respectively) . Figure 4B and grown in the presence of DOX for 20 hr to deplete endogenous Sis1p. Live cells were analyzed by DIC and fluorescence microscopy. Nuclei were counterstained with Hoechst 33342. Scale bar, 10 mm. (B) Nuclear degradation of CG*. Degradation of CG* was analyzed upon addition of CHX in wild-type cells expressing NLS-CG*, CG*, or NES-CG* under GAL1 promoter. CG* proteins were detected with anti-GFP antibody and quantified by densitometry. Averages of three independent experiments and p values for the difference in fractional CG* degradation at the 3 hr time points are indicated. PGK was used as loading control. (C) CG* and Sis1p accumulate in the nucleus upon proteasome inhibition. CG* was expressed in Dpdr5 cells for 18 hr, followed by addition of 1% DMSO or 100 mM MG132 in DMSO for 2 hr. Sis1p was immunolabeled with rabbit anti-Sis1p antibody coupled to Cy3-conjugated goat anti-rabbit antibody and CG* by GFP fluorescence. Nuclei were counterstained with DAPI. Scale bar, 10 mm. (D) CG* and Sis1p accumulate in the nucleus in Dsan1 cells. CG* was expressed in wild-type (WT) and Dsan1 cells for 18 hr and analyzed as in (C). Scale bar, 10 mm. (E) Cytoplasmic-nuclear shuttling of Sis1p is required for CG* degradation. Plasmids encoding Sis1p, NLS-Sis1p or NES-Sis1p (all N terminally HA-tagged) were introduced into Tet-Off SIS1 cells expressing CG*. Endogenous Sis1p was depleted by addition of DOX. Sis1 proteins expressed under the GAL1 promoter were immunolabeled with mouse anti-HA antibody coupled to Cy3-conjugated goat anti-mouse antibody and CG* by GFP fluorescence. Nuclei were stained with DAPI. Scale bar, 10 mm. See also Figure S5 . CmCh* strongly accumulated when cells expressed 97QG above a threshold level, as detected by FACS analysis (Figure S6D) . This was not observed in cells expressing equivalent amounts of 25QG ( Figure S6D ), indicating that the accumulation of CmCh* was due to inhibition of degradation by 97QG. Overexpression of DnaJB1 suppressed this inhibitory effect (Figure S6D) , similar to the observations with Sis1p in yeast cells ( Figure 3C ).
To investigate whether DnaJB1 has a more general role in the nuclear degradation of misfolded cytosolic proteins, we analyzed the turnover of a conformationally destabilized mutant of firefly luciferase fused to GFP (LG*) (Gupta et al., 2011) . LG* was degraded in HEK293 cells with a half-time of $3.5 hr (Figure S6E) . The protein was diffusely distributed in the cytoplasm but accumulated in nuclear and cytoplasmic inclusions upon proteasome inhibition ( Figure 6A ). Notably, NES-LG*, the cytosolic version of LG*, was stabilized (t 1/2 $6 hr) relative to LG*, whereas degradation was accelerated for NLS-LG* (t 1/2 $2 hr) ( Figure S6E ). NES-LG* nevertheless formed nuclear inclusions upon proteasome inhibition ( Figure 6A ), suggesting that it was also degraded in the nucleus. Indeed, addition of leptomycin B, a small molecule inhibitor of the nuclear exportin Crm1 (Kudo et al., 1999) , significantly accelerated the degradation of NES-LG* (t 1/2 $3 hr) ( Figure 6B) . Notably, downregulation of DnaJB1 delayed degradation ( Figure 6C ) and resulted in the formation of juxtanuclear NES-LG* inclusions ( Figure 6D ). Moreover, whereas proteasome inhibition in control cells caused the formation of nuclear NES-LG* inclusions, predominantly large cytoplasmic aggregates of NES-LG* accumulated upon downregulation of DnaJB1 in combination with proteasome inhibition ( Figure 6D ). This indicates that DnaJB1 is necessary for efficient uptake of the misfolded protein into the nucleus. Together, these results suggest that the role of Sis1p in the nuclear degradation of misfolded, cytosolic proteins is conserved in mammalian cells.
DISCUSSION
Here we established a yeast model to investigate the mechanism by which polyQ aggregation interferes with cellular protein quality control. We showed that polyQ aggregates interact with and functionally deplete the low-abundant Hsp40 chaperone Sis1p, thereby inhibiting the degradation of misfolded proteins via the UPS. This effect is explained by our finding that Sis1p is specifically required for the transfer of cytosolic misfolded proteins to the nucleus for degradation (Figure 7) , a function which is conserved in mammalian cells. These results demonstrate that the proteostasis network is highly vulnerable to pathologic protein aggregates, due to their capacity to sequester critical proteostasis regulators.
Sequestration of Sis1p by PolyQ Aggregates
Using the terminally misfolded protein CG* as a reporter, we showed that polyQ proteins inhibit the degradation of this cytosolic misfolded protein by depleting the low-abundant but essential Hsp70 regulator Sis1p. The effect of Sis1p on CG* degradation is specific, as overexpression of Ssa1p or Ydj1p fails to restore CG* clearance in 96Q expressing cells. Although these abundant chaperones contribute to CG* degradation (Park et al., 2007) , they are not limiting under the conditions of polyQ expression analyzed here. We find that $50% of total Sis1p is associated with insoluble 96Q inclusions. Additionally, $50% of the remaining soluble Sis1p is associated with soluble 96Q species. Importantly, a $25% reduction in the total Sis1p was sufficient to slow the turnover of CG*, independent of 96Q expression (Figure 4) . Thus, sequestration of Sis1p by the polyQ aggregates explains the observed inhibition of CG* degradation, although aberrant interactions of the aggregates with other factors may also contribute. For example, we identified several components of the nuclear pore complex as 96Q interactors (Table S1 ), which may add to the observed defect in nuclear uptake of misfolded proteins.
The present study describes mechanisms that may contribute generally to cellular polyQ toxicity. Indeed, Hsp40 proteins have been observed in mammalian cell models in association with the aggregates of different polyQ proteins (Hageman et al., 2010) . Specifically, the close homolog of Sis1p, DnaJB1, was found in polyQ inclusions of postmortem brain tissue from spinocerebellar ataxia type 3 (SCA3) patients (Chai et al., 1999) , consistent with our finding that Sis1p associates with aggregates of a C-terminal fragment of ataxin 3 in the yeast model. A recent quantitative analysis of aggregation profiles in SCA3 brains showed that in a subset of pontine neurons, DnaJB1 was sequestered into nuclear inclusions of ataxin 3 and depleted from the cytosol (Seidel et al., 2012) . Moreover, DnaJB protein levels in patient fibroblasts were found to correlate inversely with the age of onset and the severity of SCA3 (Zijlstra et al., 2010) .
Role of Sis1p in Nuclear Degradation of Cytosolic Misfolded Proteins
The nuclear degradation of misfolded cytosolic proteins in yeast has previously been reported (Heck et al., 2010; Prasad et al., 2010) , but how these proteins are specifically sorted to the nucleus had remained unclear. Our study identified Sis1p as a critical component in this process. Indeed, in addition to the reporter protein used here, Sis1p is also required for the degradation of terminally misfolded mutant GFP, as reported recently (Summers et al., 2013) . Similar to CG*, this protein was found to be rapidly degraded in a Ubr1-dependent manner, but it formed cytoplasmic inclusions at low Sis1p levels. In light of our findings, it is likely that Sis1p functions in transferring the mutant GFP protein to the nucleus for degradation. Whether misfolded cytosolic proteins are generally degraded in the nucleus remains to be determined, but it seems plausible that the Sis1p independent, regulatory degradation of proteins like FBPase is performed by cytosolic proteasome complexes. In any case, the accumulation of misfolded protein species upon Sis1p depletion may well explain why cells cannot tolerate the loss of Sis1p, although other roles in proteostasis may contribute to the essential nature of this chaperone.
Sis1p cooperates in protein degradation with Ssa class Hsp70s, presumably by binding to preformed Ssa/Ydj1p/ substrate complexes or by replacing Ydj1p in such complexes ( Figure 7 ). As ubiquitylation of CG* was not impaired by Sis1p depletion, recruitment of Sis1p may occur before or after ubiquitylation. It is possible that Sis1p has a high affinity for misfolded, ubiquitylated proteins and thus may effectively stabilize their interaction with Hsp70 ( Figure 7) . In any case, association with Sis1p will shift the fate of bound client protein from (attempted) refolding to degradation, based on the ability of Sis1p, but not Ydj1p, to mediate import into the nucleus where the majority of cellular proteasome complexes reside. The low abundance of (B) Degradation of NES-LG* is accelerated by inhibition of nuclear export. NES-LG* cells were treated with 10 ng/ml of leptomycin B or ethanol control and degradation of NES-LG* assessed upon addition of CHX (140 mg/ml). NES-LG* was detected by immunoblotting with anti-GFP antibody and quantified by densitometry. Averages ± SD from six independent experiments and the p value for the difference in fractional NES-LG* degradation at the 9 hr time point are shown.
(C) Downregulation of DnaJB1 retards degradation of NES-LG*. Degradation of NES-LG* was analyzed as in (B) in cells transfected either with control siRNA or DnaJB1 siRNA ( Figure S6 and Extended Experimental Procedures). Averages ± SD from three independent experiments with downregulation of DnaJB1 being >75% are shown. p value is indicated as in (B).
(D) DnaJB1 is required for shuttling of LG* into the nucleus for degradation. NES-LG* was stably expressed in cells transfected either with control siRNA or DnaJB1 siRNA and treated either with MG132 or DMSO for 8 hr as in (A). NES-LG* was visualized by GFP fluorescence and nuclei were stained with DAPI. Scale bars, 10 mm. See also Figure S6 .
Sis1p compared to Ydj1p (20,000 and 120,000 molecules per cell, respectively; SGD, http://www.yeastgenome.org), coupled with the limited capacity of the cytosolic proteasome system, would ensure that misfolded proteins are selected for nuclear degradation only after multiple attempts at refolding. Thus, Sis1p performs a triage function conceptually similar to that of the ER chaperone machinery in selecting substrates for ERAD. Whether Sis1p interacts directly with nuclear importins remains to be determined, but a specific role of Sis1p in nuclear transfer is supported by several lines of evidence: CG* and Sis1p accumulate in the nucleus after proteasome inhibition, triggering the deposition of juxtanuclear CG* inclusions. Neither nuclear nor cytosolic versions of Sis1p (NLS-Sis1p and NES-Sis1p) can functionally replace wild-type Sis1p for protein degradation, suggesting a model in which Sis1p shuttles between cytosol and nucleus ( Figure 7 ). Re-export of Sis1p to the cytosol is apparently coupled with the transfer of misfolded protein to the nuclear proteasome machinery, and this step is disrupted when Sis1p carries a nuclear export signal. We demonstrated that the nuclear pathway for the degradation of misfolded cytosolic proteins also exists in mammalian cells, with DnaJB1 having a role similar to Sis1p. It will be important to analyze this pathway in more detail. For example, DnaJB1 may cooperate in protein clearance with the cytosolic E3 ligase CHIP (Connell et al., 2001) , not present in yeast, and with the Hsp90 chaperone system (McClellan et al., 2005) . Moreover, mammalian cells contain multiple DnaJB proteins, which could be specialized in mediating the degradation of misfolded proteins with different structural properties. Misfolded proteins such as CG* (green) are initially stabilized in a soluble state by Hsp70s of the Ssa class, probably in cooperation with the abundant Hsp40, Ydj1. Attempted refolding through protein binding and release, and eventually ubiquitylation by Ubr1 (presumably by CHIP in mammalian cells) may occur. Recognition of misfolded protein by Sis1p dimer leads to remodeling of the initial chaperone complex, shifting from refolding to degradation mode. Sis1p stabilizes the association with Hsp70 and mediates protein import into the nucleus for proteasomal degradation. The nuclear E3 ligase San1, acting in parallel to cytosolic E3 ligases, contributes to efficient ubiquitylation. Red arrows indicate reactions occurring in cells containing polyQ aggregates that deplete Sis1p. See Discussion for details.
Cycloheximide Chase Experiments
Cells were transferred from SC medium containing 2% glucose to SC medium containing 2% raffinose and 2% galactose to induce the galactose-regulated expression of reporter protein for 15-18 hr. Cycloheximide (0.5 mg/ml) was added and 2 OD 600 of cells were removed at the indicated time points. Total cell extracts were prepared by alkaline-lysis, ensuring complete solubilization of the reporter protein analyzed, followed by immunoblotting with antibodies as indicated (Park et al., 2007) .
Fluorescence Imaging
Fluorescence imaging of live yeast cells was performed using a Zeiss Axiovert 200M inverted fluorescence microscope and AxioVision 4.7.1 for image analysis. Hoechst 33342 dye and DAPI were used for nuclear staining of live and fixed cells, respectively. Confocal microscopy of HEK293 cells was performed using the Leica TCS SP2 confocal laser scanning microscope (Leica Microsystems) equipped with Acousto-Optical Beam Splitter (AOBS) (see Extended Experimental Procedures).
SILAC Labeling and PolyQ-Interactor Analysis by LC-MS/MS
Yeast cells were grown over night in CM Ura-His-glucose medium containing either 100 mg/l unlabeled (light) L-lysine (L) or 100 mg/l heavy L-lysine-13 C 6 , 15 N 2 (H) (Ong and Mann, 2006) . For the expression of galactose-inducible proteins (CG* and polyQ proteins), labeled cells were grown in the same medium but containing 2% raffinose and 2% galactose instead of glucose for at least six generations until an OD 600 of 0.8. Cell extracts were prepared in lysis buffer (25 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mM MgCl 2 , 1 mM EDTA, 5% glycerol, 0.5% Triton X-100, complete protease inhibitors [Roche] ) and cleared by centrifugation (10 min, 20,000 3 g at 4 C). Myc-tagged proteins were isolated with anti-myc MicroBeads (Miltenyi Biotech) by incubation for 2 hr at 4 C. After three washes with lysis buffer, bound proteins were eluted with urea buffer (8 M urea, 5% SDS, 200 mM Tris-HCl [pH 6.8], 1 mM EDTA 0.1% bromophenol blue, 1.5% 2-mercaptoethanol) and (L) and (H)-eluates mixed 1:1, followed by SDS-PAGE, in-gel digestion and LC-MS/MS analysis (see Extended Experimental Procedures for details).
Mammalian Cell Culture
Human HEK293 cells were cultured under standard conditions (Gupta et al., 2011 ) (see Extended Experimental Procedures). Transient transfections were performed with FuGene 6 according to the manufacturer's protocol.
Miscellaneous
Filter-trap assays to detect polyQ aggregates, immunoprecipitation experiments, and the isolation of His 6 -Ub conjugated proteins were performed as described in Extended Experimental Procedures). Immunoblots were developed using the chemiluminescence kit Rodeo ECL (USB) and analyzed using a LAS-3000 image reader (Fujifilm) and the AIDA software (Raytest).
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